<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px">
<tr>
<td>Protocol#: B-20190028<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Declan  McCole</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">dmccole@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Biomedical Sciences</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951) 827-7785</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">2/1/2013-2/1/2023</td>   <th class="THBlue">Fax</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Effects of Inflammation and Infection on Intestinal Epithelial Biology</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">NIH R01DK091281 MCCOLE 
AMER PHYSIOLOGICAL SOC-MCCOLE
CCFA 370082 MCCOLE 
S&amp;R FDN 16121300 MCCOLE
PFIZER W1214999 MCCOLE 
PI WI227049 MCCOLE 
Start Up Funds</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2">Alina Santos 951-827-7787</td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">SOM&#160;&#160;&#160;</td>   <td class="TDBlue">342&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM &#160;&#160;&#160;</td>   <td class="TDBlue">341&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM &#160;&#160;&#160;</td>   <td class="TDBlue">333&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM&#160;&#160;&#160;</td>   <td class="TDBlue">241&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOM&#160;&#160;&#160;</td>   <td class="TDBlue">233&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB&#160;&#160;&#160;</td>   <td class="TDBlue">314&#160;&#160;&#160;</td>   <td class="TDBlue">2- Biological Safety Cabinets, Class II, Type A2&#160;&#160;&#160;</td>   <td class="TDBlue">4/25/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB &#160;&#160;&#160;</td>   <td class="TDBlue">310C&#160;&#160;&#160;</td>   <td class="TDBlue">Fume Hood Safety Cabinet&#160;&#160;&#160;</td>   <td class="TDBlue">6/7/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB &#160;&#160;&#160;</td>   <td class="TDBlue">310 Lab 2&#160;&#160;&#160;</td>   <td class="TDBlue">Main Lab Bench Space and Equipment&#160;&#160;&#160;</td>   <td class="TDBlue">5/2/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB&#160;&#160;&#160;</td>   <td class="TDBlue">310B&#160;&#160;&#160;</td>   <td class="TDBlue">-80C, -20C, N2(l) tank, plus other minor equipment&#160;&#160;&#160;</td>   <td class="TDBlue">5/2/2019&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Spieth Vivarium&#160;&#160;&#160;</td>   <td class="TDBlue">359&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB FACS RM&#160;&#160;&#160;</td>   <td class="TDBlue">233&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB MICROSCOPY &#160;&#160;&#160;</td>   <td class="TDBlue">241&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB Nordgren Lab&#160;&#160;&#160;</td>   <td class="TDBlue">230&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB DiPatrizio Lab&#160;&#160;&#160;</td>   <td class="TDBlue">210&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">SOMRB Autoclave&#160;&#160;&#160;</td>   <td class="TDBlue">341&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Psychology Vivarium (SPF)&#160;&#160;&#160;</td>   <td class="TDBlue">1419&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">Renewal BUA#20160034</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">Pending</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A2019001B &amp; AUP20160023E</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue">4/12/16 &amp; 8/3/16</td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">The McCole Lab aims to understand the effects of inflammation on epithelial barrier function incorporating electrophysiology, molecular biology, biochemical and imaging approaches both in vitro and in vivo model systems. We also translate our studies to human disease using intestinal biopsies from IBD patients. We will be obtaining intestinal biopsies from Riverside County Regional Medical Center through a collaboration with a gastroenterologist, Dr. Henry Nguyen. In addition, we are investigating novel treatments to restore barrier function. We will also seek to determine if various strains of intestinal commensal bacteria can infect mouse and human cell lines, and whether these bacteria influence mice and/or human cells by performing gene expression and protein analyses. One method involves studying movement of bacterial molecules into host cells using approaches such as use of methionine analogs AHA and ANL, the latter of which require bacteria be transformed with the pAM1 plasmid (which contains a modified version of the methionyl-tRNA synthetase gene). With a few exceptions being BSL2 bacterial strains, most bacterial and eukaryotic cell lines have been classified as BSL1 by ATCC. Intestinal commensal bacteria include but are not limited to: Clostridium ramosum, Bacteroides vulgatus, Clostridium innocuum, Lactobacillus johnsonii, Lactobacillus animalis, Escherichia coli, Enterococcus faecium.</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue">To understand and evaluate epithelial barrier function we utilize transgenic mice models mimicking diseased states of inflammation. Biohazardous reagents such as phenol-chloroform, Dextran sodium sulfate, EtBr, paraformaldehyde, viral constructs, etc., will be utilized to carry out the molecular techniques necessary to achieve this objective. To address the importance of the microbiome on the epithelial barrier function, we will also infect cells and live mice with infectious and commensal bacteria. Additionally, we will handle defibrinated sheep blood to prepare Brucella Blood Agar Plates (BBA) for isolation and cultivation of nonfastidious and fastidious microorganisms from a variety of clinical and nonclinical specimens. All personnel will be trained accordingly and appropriate measures taken to prevent injury as well as spread of infectious agents. SOP's for the lab have been drafted and will be available as a reference. </td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">False</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Lentivirus&#160;&#160;&#160;</td>   <td class="TDBlue">Cells/mice&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Intestinal commensal bacteria including but not limited to Clostridium ramosum, Bacteroides vulgatus, Clostridium innocuum, Lactobacillus johnsonii, Lactobacillus animalis, Escherichia coli, Enterococcus faecium&#160;&#160;&#160;</td>   <td class="TDBlue">Mammals&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Defibrinated Sheep Blood&#160;&#160;&#160;</td>   <td class="TDBlue">Sheep&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Intestinal infectious bacteria including: salmonella, citrobacter&#160;&#160;&#160;</td>   <td class="TDBlue">Mammals&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue">1. Lentiviral packaging plasmid and/or bacterial plasmids will be utilized to insert a gene into in-vitro (cell culture) or in-vivo models and bacteria. Experimental design will be performed at a low scale. 

2. Additionally, we will track movement of bacterial molecules into host cells using several approaches including use of methionine analogs AHA and ANL, the latter of which requires the bacteria be transformed with the pAM1 plasmid that contains a modified version of the methionyl-tRNA synthetase gene

3. Commensal and pathogenic bacteria will be introduced into mice (control, transgenic, antibiotic-treated and germ-free) to study colonization (of the gastrointestinal tract), interaction with other bacteria (commensal and pathogenic) and effects on host physiology and immune responses.

4. Defibrinated sheep blood will be handled to make BBA plates to isolate and cultivate nonfastidious and fastidious microorganisms from a variety of clinical and nonclinical specimens.
</td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue">Follow the SOP drafted for the McCole lab as well as laboratory safety procedures. </td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">1. The following cells lines will be used for in vitro studies; Caco2-BBE(human epithelial colorectal adenocarcinoma cell); T84 (eptihelial cells; CCL-248 ATCC); HEK-293T (human kidney cells, CRL-11268 ATCC). Additionally, we will perform routine cell culture and molecular biology based experiments with and without intestinal bacteria to determine if these bacteria can infect the eukaryotic cell lines and/or influence their functioning (via gene expression and/or protein based analyses). 
2. Intestinal biopsies will be obtained from Riverside County Regional Medical Center and transported in a sealed container containing cold physiological solution. This container will be secured within an outer container containing ice. The container &amp; contents will be transported by car back to UCR.
3. Defibrinated sheep blood, commercially available for preparation of BBA plates.
4. In separate experiments as described in IACUC approved protocols, we will use commensal and/or infectious bacteria </td>
</tr>
</table>
<br><div class="hdg2">Recombinant DNA</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">General features of the DNA &#160;&#160;&#160;</th>   <th class="THBlue">Species from which DNA originated &#160;&#160;&#160;</th>   <th class="THBlue">Species to receive DNA, type of vector, and transformation method &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">We will track the movement of bacterial molecules into host cells using approaches including the use of methionine analogs AHA and ANL, the latter of which requires bacteria be transformed with the pAM1 plasmid, which contains a modified version of methionyl-tRNA synthetase gene. &#160;&#160;&#160;</td>   <td class="TDBlue">Escherichia coli&#160;&#160;&#160;</td>   <td class="TDBlue">Clostridium ramosum, Bacteroides vulgatus, Clostridium innocuum, Lactobacillus johnsonii, Lactobacillus animalis, Escherichia coli, Enterococcus faecium, pAm1 plasmid. Transformation method: Electroporation &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Our work focuses on the Protein Tyrosine Phosphatase N2 (PTPN2) gene that has been identified as a genetic marker associated with several diseases like IBD, type 1 diabetes, and celiac disease&#160;&#160;&#160;</td>   <td class="TDBlue">-pLK).1 (control or PTPN2, both commercially available)
-Envelope and packaging plasmid will be obtained/gifted from James R. Goldenring, Vanderbilt University, Nashville.) &#160;&#160;&#160;</td>   <td class="TDBlue">cultured epithelial cells (Caco2, T84, HT-29)&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Lentiviral packaging   	&#160;&#160;&#160;</td>   <td class="TDBlue">pMD2.G (lentiviral ENV plasmid) and pR8.2 (lentiviral packaging plasmid) from Addgene&#160;&#160;&#160;</td>   <td class="TDBlue">Retrovirus-based plasmid    
&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Will cultures of any recombinant organisms listed above exceed a volume of 10 liters?  </th>   <td width="50%" class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If so, where will the cultures be grown?</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Does your experiment involve the transfer of a drug resistance trait to any microorganism, plant, or insect that does not acquire that trait naturally?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards of the experiments, including whether acquiring such a trait would compromise the use of the drug in medicine or agriculture.</th>   <td class="TDBlue">Typical ampicillin resistant plasmids transferred to standard E.coli bacterium. No threats posed as waste will be handled according to the drafted SOP. </td>
</tr>
<tr>   <th class="THBlue">Are you expressing genes encoding toxins with LD 50 less that 10 ng/kg of body weight?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the toxic product and safety precautions.</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Are you using hosts or vectors of rDNA (excluding E. coli K-12) that are viable pathogens of animals, plants, or microbes?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Are you using recombinant DNA molecules containing the partial genome of any eukaryotic (plant or animal) virus?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the molecules, including genetic maps and the fraction of virus genome present, and safety precautions.</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Are your experiments likely to enhance the pathogenicity or extend the host range of a viral vector (e.g., introduction of novel control elements or a oncogene)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the hazards and safety precautions.</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Will you be using genes involved in cell cycle control in animals (oncogene, tumor suppressor, cytokine, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, describe the potential hazards.</th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes&#8221;, list your recommendations in section 5.</th>   <td class="TDBlue">N/A</td>
</tr>
</table>
<br><div class="hdg2">Vertebrates</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Animal &#160;&#160;&#160;</th>   <th class="THBlue">Infectious Agent &#160;&#160;&#160;</th>   <th class="THBlue">Route(s) of Shedding/Excretion of Infectious Agents &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">Human and mice cell lines&#160;&#160;&#160;</td>   <td class="TDBlue">Clostridium ramosum, Bacteroides vulgatus, Clostridium innocuum, Lactobacillus johnsonii, Lactobacillus animalis, Escherichia coli, Enterococcus faecium, pAM1 plasmid via transformation method: electroporation&#160;&#160;&#160;</td>   <td class="TDBlue">Cell culture supernatant &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">live mice&#160;&#160;&#160;</td>   <td class="TDBlue">Clostridium ramosum, Bacteroides vulgatus, Clostridium innocuum, Lactobacillus johnsonii, Lactobacillus animalis, Escherichia coli, Enterococcus faecium, method: oral gavage&#160;&#160;&#160;</td>   <td class="TDBlue">bodily fluids: urine, blood, feces &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Live Mice&#160;&#160;&#160;</td>   <td class="TDBlue">Infectious bacteria: saslmonella, citrobacter&#160;&#160;&#160;</td>   <td class="TDBlue">bodily fluids: Urine, blood, feces&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using human or primate cells in animals?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you infecting animals with infectious agents?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">Infected mice carcasses will be placed in a red biohazard bag in the -20C storage space provided by the vivarium. Carcases will then be incinerated off campus as routinely arranged by the vivarium. Infected bedding will be sterilized before disposal.</td>
</tr>
<tr>   <th class="THBlue">Do the animals shed the infectious agents?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; how long will shedding of the infectious agent occur?</th>   <td class="TDBlue">Cell lines: in their own culture media. 
Live mice: all bodily fluids (ie: urine, blood, feces)</td>
</tr>
<tr>   <th class="THBlue">Are you using animals that have been caught in the wild?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are there potential zoonotic diseases associated with the animals?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; describe any potential environmental or health hazards, containment precautions, and disposal protocols.</th>   <td class="TDBlue">N/A</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">1. Investigators will wear eye safety glasses, laboratory coats, and gloves
2. Containment/storage of chemicals/agents according to MSDS. Viable biological materials will be handled in an annually certified biological safety cabinet.
3. Sharps used with viable biological materials are handled as follows: contaminated broken glassware will not be handled directly by hand, but instead will be removed by using a brush and dust pan, tongs, or forceps, and they will be decontaminated prior to disposal. 
4. Cultures will be placed in a container with a cover that prevents leakage during handling, processing, or storage. 
5. Decontaminate surfaces/spills/waste in 10% bleach or germicidal detergent
6. Autoclave glassware. Dispose of autoclaved plastics/solid waste. 
7. Mouth pipetting will be prohibited, mechanical pipetting devices will be used. 
8. Investigators will wash their hands after they handle viable materials.
9. Eating, drinking, smoking, handling contact lenses, and applying cosmetics will not be permitted in the work areas. Food will be stored outside the work area in cabinets or refrigerators designated for this purpose only.
10. A biohazard sign will be posted on the entrance to the laboratory. </td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue">N/A</td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 7/26/2019 12:59:32 PM by <b>Alina Santos</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckedBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><br><br>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Peter Atkinson</b></u></em> __________________________7/28/2019</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    
</td>
</tr>
</table>
</form>
</body>
</html>
